loadpatents
name:-0.086007833480835
name:-0.064723968505859
name:-0.033807992935181
Wiles; Jason Allan Patent Filings

Wiles; Jason Allan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wiles; Jason Allan.The latest application filed is for "quinazoline and indole compounds to treat medical disorders".

Company Profile
35.64.84
  • Wiles; Jason Allan - Madison CT
  • Wiles; Jason Allan - Hamden CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical compounds for treatment of medical disorders
Grant 11,447,465 - Wiles , et al. September 20, 2
2022-09-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 11,407,738 - Wiles , et al. August 9, 2
2022-08-09
Quinazoline And Indole Compounds To Treat Medical Disorders
App 20220119400 - WILES; Jason Allan ;   et al.
2022-04-21
Quinazoline and indole compounds to treat medical disorders
Grant 11,248,000 - Wiles , et al. February 15, 2
2022-02-15
Macrocyclic Compounds For Treatment Of Medical Disorders
App 20210300934 - WILES; Jason Allan ;   et al.
2021-09-30
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20210269458 - WILES; Jason Allan ;   et al.
2021-09-02
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
Grant 11,084,800 - Wiles , et al. August 10, 2
2021-08-10
Macrocyclic compounds for treatment of medical disorders
Grant 11,053,253 - Wiles , et al. July 6, 2
2021-07-06
Disubstituted compounds for treatment of medical disorders
Grant 11,001,600 - Wiles , et al. May 11, 2
2021-05-11
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210122733 - WILES; Jason Allan ;   et al.
2021-04-29
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210115034 - Wiles; Jason Allan ;   et al.
2021-04-22
Quinazoline and indole compounds to treat medical disorders
Grant 10,961,252 - Wiles , et al. March 30, 2
2021-03-30
Amide compounds for treatment of immune and inflammatory disorders
Grant 10,919,884 - Wiles , et al. February 16, 2
2021-02-16
Amino compounds for treatment of immune and inflammatory disorders
Grant 10,906,887 - Wiles , et al. February 2, 2
2021-02-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,822,352 - Wiles , et al. November 3, 2
2020-11-03
Compounds for treatment of immune inflammatory disorders
Grant 10,807,952 - Wiles , et al. October 20, 2
2020-10-20
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20200262818 - Wiles; Jason Allan ;   et al.
2020-08-20
Amino compounds for treatment of complement mediated disorders
Grant 10,689,409 - Gadhachanda , et al.
2020-06-23
Quinazoline and Indole Compounds to Treat Medical Disorders
App 20200165262 - Wiles; Jason Allan ;   et al.
2020-05-28
Amino compounds for treatment of medical disorders
Grant 10,660,876 - Wiles , et al.
2020-05-26
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 10,662,175 - Wiles , et al.
2020-05-26
Aryi, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders
App 20200071301 - Wiles; Jason Allan ;   et al.
2020-03-05
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20200062790 - Wiles; Jason Allan ;   et al.
2020-02-27
Ether compounds for treatment of complement mediated disorders
Grant 10,550,140 - Wiles , et al. Fe
2020-02-04
Macrocyclic Compounds For Treatment Of Medical Disorders
App 20200002347 - Wiles; Jason Allan ;   et al.
2020-01-02
Pharmaceutical Compounds For Treatment Of Medical Disorders
App 20190382376 - Wiles; Jason Allan ;   et al.
2019-12-19
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,464,956 - Wiles , et al. No
2019-11-05
Compounds for treatment of complement mediated disorders
Grant 10,428,095 - Wiles , et al. October 1, 2
2019-10-01
Amide compounds for treatment of complement mediated disorders
Grant 10,428,094 - Wiles , et al. October 1, 2
2019-10-01
Ether compounds for treatment of medical disorders
Grant 10,385,097 - Wiles , et al. A
2019-08-20
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 10,370,394 - Wiles , et al.
2019-08-06
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20190211033 - Wiles; Jason Allan ;   et al.
2019-07-11
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190185498 - Wiles; Jason Allan ;   et al.
2019-06-20
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,301,336 - Wiles , et al.
2019-05-28
Amino Compounds For Treatment Of Complement Mediated Disorders
App 20190144473 - Gadhachanda; Venkat Rao ;   et al.
2019-05-16
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,287,301 - Wiles , et al.
2019-05-14
Quinazoline and Indole Compounds to Treat Medical Disorders
App 20190135825 - Wiles; Jason Allan ;   et al.
2019-05-09
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,253,053 - Wiles , et al.
2019-04-09
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20190085005 - Wiles; Jason Allan ;   et al.
2019-03-21
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20190048033 - Wiles; Jason Allan ;   et al.
2019-02-14
Compounds For Treatment Of Complement Mediated Disorders
App 20190031692 - Wiles; Jason Allan ;   et al.
2019-01-31
Amino compounds for treatment of complement mediated disorders
Grant 10,189,869 - Gadhachanda , et al. Ja
2019-01-29
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190023729 - Wiles; Jason Allan ;   et al.
2019-01-24
Amide compounds for treatment of medical disorders
Grant 10,138,225 - Wiles , et al. Nov
2018-11-27
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180303800 - Wiles; Jason Allan ;   et al.
2018-10-25
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20180305375 - Wiles; Jason Allan ;   et al.
2018-10-25
Ether compounds for treatment of complement mediated disorders
Grant 10,106,563 - Wiles , et al. October 23, 2
2018-10-23
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20180298043 - Wiles; Jason Allan ;   et al.
2018-10-18
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,100,072 - Wiles , et al. October 16, 2
2018-10-16
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291047 - Wiles; Jason Allan ;   et al.
2018-10-11
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291046 - Wiles; Jason Allan ;   et al.
2018-10-11
Compounds for the treatment of medical disorders
Grant 10,092,584 - Wiles , et al. October 9, 2
2018-10-09
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
Grant 10,092,547 - Wiles , et al. October 9, 2
2018-10-09
Compounds for treatment of complement mediated disorders
Grant 10,087,203 - Wiles , et al. October 2, 2
2018-10-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,081,645 - Wiles , et al. September 25, 2
2018-09-25
Compounds For Treatment Of Immune Inflammatory Disorders
App 20180201580 - Wiles; Jason Allan ;   et al.
2018-07-19
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180186782 - Wiles; Jason Allan ;   et al.
2018-07-05
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,011,612 - Wiles , et al. July 3, 2
2018-07-03
Disubstituted Compounds For Treatment Of Medical Disorders
App 20180179236 - Wiles; Jason Allan ;   et al.
2018-06-28
Amino Compounds For Treatment Of Medical Disorders
App 20180177761 - Wiles; Jason Allan ;   et al.
2018-06-28
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179186 - Wiles; Jason Allan ;   et al.
2018-06-28
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179185 - Wiles; Jason Allan ;   et al.
2018-06-28
Amide compounds for treatment of complement mediated disorders
Grant 10,005,802 - Wiles , et al. June 26, 2
2018-06-26
Phosphonate compounds for treatment of medical disorders
Grant 10,000,516 - Wiles , et al. June 19, 2
2018-06-19
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180072762 - Wiles; Jason Allan ;   et al.
2018-03-15
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180055824 - Wiles; Jason Allan ;   et al.
2018-03-01
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20180030075 - Wiles; Jason Allan ;   et al.
2018-02-01
Compounds for Treatment of Complement Mediated Disorders
App 20180022767 - Wiles; Jason Allan ;   et al.
2018-01-25
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20180022766 - Wiles; Jason Allan ;   et al.
2018-01-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,833,440 - Wiles , et al. December 5, 2
2017-12-05
Alkyne compounds for treatment of complement mediated disorders
Grant 9,828,396 - Wiles , et al. November 28, 2
2017-11-28
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 9,796,741 - Gadhachanda , et al. October 24, 2
2017-10-24
Carbamate, Ester, And Ketone Compounds For Treatment Of Complement Mediated Disorders
App 20170298085 - Wiles; Jason Allan ;   et al.
2017-10-19
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20170298084 - Wiles; Jason Allan ;   et al.
2017-10-19
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20170260219 - Wiles; Jason Allan ;   et al.
2017-09-14
Compounds for treatment of complement mediated disorders
Grant 9,758,537 - Wiles , et al. September 12, 2
2017-09-12
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 9,732,103 - Wiles , et al. August 15, 2
2017-08-15
Ether compounds for treatment of complement mediated disorders
Grant 9,732,104 - Gadhachanda , et al. August 15, 2
2017-08-15
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20170226142 - Wiles; Jason Allan ;   et al.
2017-08-10
Amino Compounds for Treatment of Complement Mediated Disorders
App 20170189410 - Gadhachanda; Venkat Rao ;   et al.
2017-07-06
Amide compounds for treatment of complement mediated disorders
Grant 9,695,205 - Wiles , et al. July 4, 2
2017-07-04
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170157096 - Wiles; Jason Allan ;   et al.
2017-06-08
Phosphonate compounds for treatment of complement mediated disorders
Grant 9,663,543 - Wiles , et al. May 30, 2
2017-05-30
Factor D inhibitors useful for treating inflammatory disorders
Grant 9,643,986 - Wiles , et al. May 9, 2
2017-05-09
Amino compounds for treatment of complement mediated disorders
Grant 9,598,446 - Gadhachanda , et al. March 21, 2
2017-03-21
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,592,222 - Wiles , et al. March 14, 2
2017-03-14
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders
App 20170066783 - Wiles; Jason Allan ;   et al.
2017-03-09
Amide Compounds for Treatment of Medical Disorders
App 20170057950 - Wiles; Jason Allan ;   et al.
2017-03-02
Compounds for the Treatment of Medical Disorders
App 20170056428 - Wiles; Jason Allan ;   et al.
2017-03-02
Phosphonate Compounds for Treatment of Medical Disorders
App 20170057983 - Wiles; Jason Allan ;   et al.
2017-03-02
Ether Compounds for Treatment of Medical Disorders
App 20170057993 - Wiles; Jason Allan ;   et al.
2017-03-02
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170007579 - Wiles; Jason Allan ;   et al.
2017-01-12
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20160362398 - Wiles; Jason Allan ;   et al.
2016-12-15
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20160362432 - Wiles; Jason Allan ;   et al.
2016-12-15
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20160362433 - Wiles; Jason Allan ;   et al.
2016-12-15
Compounds For Treatment Of Complement Mediated Disorders
App 20160361329 - Wiles; Jason Allan ;   et al.
2016-12-15
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20160362399 - Wiles; Jason Allan ;   et al.
2016-12-15
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,474,742 - Wiles , et al. October 25, 2
2016-10-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,468,629 - Wiles , et al. October 18, 2
2016-10-18
Highly active nucleoside derivative for the treatment of HCV
Grant 9,447,132 - Deshpande , et al. September 20, 2
2016-09-20
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160115157 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160113907 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,273,082 - Wiles , et al. March 1, 2
2016-03-01
Stabilized Nucleotides For Medical Treatment
App 20160016986 - Deshpande; Milind ;   et al.
2016-01-21
Biphenyl imidazoles and related compounds useful for treating HCV infections
Grant 9,125,904 - Wiles , et al. September 8, 2
2015-09-08
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20150239868 - Pais; Godwin ;   et al.
2015-08-27
Amino Compounds for Treatment of Complement Mediated Disorders
App 20150239894 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Ether Compounds for Treatment of Complement Mediated Disorders
App 20150239920 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders
App 20150239895 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20150239837 - Wiles; Jason Allan ;   et al.
2015-08-27
Amide Compounds for Treatment of Complement Mediated Disorders
App 20150239893 - Wang; Qiuping ;   et al.
2015-08-27
Phosphonate Compounds for Treatment of Complement Mediated Disorders
App 20150239921 - Wiles; Jason Allan ;   et al.
2015-08-27
Compounds for Treatment of Complement Mediated Disorders
App 20150239838 - Phadke; Avinash S. ;   et al.
2015-08-27
Carbamate, Ester, and Ketone Compounds for Treatment of Complement Mediated Disorders
App 20150239919 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,946,422 - Bradbury , et al. February 3, 2
2015-02-03
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20140323458 - Wiles; Jason Allan ;   et al.
2014-10-30
Highly Active Nucleoside Derivative For The Treatment Of Hcv
App 20140309189 - Deshpande; Milind ;   et al.
2014-10-16
Deuterated Nucleoside Prodrugs Useful For Treating Hcv
App 20140309164 - Deshpande; Milind ;   et al.
2014-10-16
NS5A inhibitors useful for treating HCV
Grant 8,835,456 - Wiles , et al. September 16, 2
2014-09-16
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 8,809,313 - Wiles , et al. August 19, 2
2014-08-19
2-substituted-thienoquinolones And Related Compounds As Anti-infective Agents
App 20130165471 - Phadke; Avinash ;   et al.
2013-06-27
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20120302538 - Wiles; Jason Allan ;   et al.
2012-11-29
New Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20120114601 - Bradbury; Barton James ;   et al.
2012-05-10
Hydroxylthienoquinolones and related compounds as anti-infective agents
Grant 8,173,636 - Bradbury , et al. May 8, 2
2012-05-08
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
Grant 8,138,346 - Bradbury , et al. March 20, 2
2012-03-20
8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones And Related Compounds As Anti-infective Agents
App 20120040959 - Bradbury; Barton James ;   et al.
2012-02-16
Isothiazoloquinolones and related compounds as anti-infective agents
Grant 8,114,888 - Bradbury , et al. February 14, 2
2012-02-14
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,044,204 - Bradbury , et al. October 25, 2
2011-10-25
Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20110223132 - Bradbury; Barton James ;   et al.
2011-09-15
Method For Synthesis Of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
App 20110213152 - Bradbury; Barton James ;   et al.
2011-09-01
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
Grant 7,902,365 - Bradbury , et al. March 8, 2
2011-03-08
Hydroxythienoquinolones And Related Compounds As Anti-infective Agents
App 20100256112 - BRADBURY; Barton James ;   et al.
2010-10-07
1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
Grant 7,659,399 - Bradbury , et al. February 9, 2
2010-02-09
4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,- 9h)-diones And Related Compounds As Anti-infective Agents
App 20090012071 - Bradbury; Barton James ;   et al.
2009-01-08
Method For Synthesis Of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
App 20080071086 - Bradbury; Barton James ;   et al.
2008-03-20
1-Thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
App 20070129333 - Bradbury; Barton James ;   et al.
2007-06-07
8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
Grant 7,199,128 - Bradbury , et al. April 3, 2
2007-04-03
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
App 20070049586 - Bradbury; Barton James ;   et al.
2007-03-01
New isothiazoloquinolones and related compounds as anti-infective agents
App 20060235041 - Bradbury; Barton James ;   et al.
2006-10-19
8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
App 20060173026 - Bradbury; Barton J. ;   et al.
2006-08-03
8A,9-dihydro-4aH-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
App 20060100215 - Bradbury; Barton J. ;   et al.
2006-05-11
Isothiazoloquinolones and related compounds as anti-infective agents
App 20050075363 - Bradbury, Barton James ;   et al.
2005-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed